Diabetes Mellitus: Types, Symptoms, Causes, Treatment, and Preventative Procedures

Abstract

The metabolic disorder diabetes mellitus maintains long-term status as a medical condition because of low insulin levels or decreased insulin sensitivity, leading to high blood glucose levels. The medical condition presents itself as a large-scale health crisis that spreads across the millions of people worldwide. The article examines diabetes mellitus through its different types, symptoms, causes, treatment options, and prevention methods. Practical prevention and management methods prove essential for lowering the number of complications that stem from this disease.

Introduction

The chronic metabolic disorder known as diabetes mellitus features abnormally high blood glucose because of insulin deficit or resistance (American Diabetes Association, 2022). Diabetes mellitus exists as a worldwide health problem which in 2021 affected 537 million adults and experts predict further rises to 2045 (IDF, 2021). DM causes critical health complications because it produces severe effects on cardiovascular systems and damages kidneys as well as nerve dysfunction (Forbes & Cooper, 2019). The primary diabetes categories consist of T1DM, T2DM, and BDM according to Buchanan & Xiang (2021). Effective patient management requires lifestyle improvements along with medication treatment and early interventions to prevent complications while improving health outcomes (DeFronzo et al., 2018).

Types of Diabetes Mellitus

Different types of diabetes mellitus exist which are categorized according to etiological origins and physiologic processes. The main diabetes types consist of type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) as well as gestational diabetes mellitus (GDM) according to the American Diabetes Association (2022).

Type 1 Diabetes Mellitus

T1DM develops when autoimmune factors destroy pancreatic beta cells which create an absolute insulin shortage (Knip et al., 2020). Children together with young adults make up the main clients who develop T1DM but individuals of any age can get this diabetes type. The treatment of T1DM demands permanent insulin administration because patients need both blood sugar regulation and protection against diabetic ketoacidosis complications (Gale 2020). The combination of genetic risk factors and environmental factors including viral infections leads to the development of T1DM according to Zimmet et al. (2021) (Gale, 2020) and Knip et al. (2020).

Type 2 Diabetes Mellitus

T2DM represents the most widespread diabetes form worldwide since it constitutes between 90–95 percent of total cases (WHO, 2021). The disease emerges when insulin resistance unites with relative insulin deficiency because of obesity in combination with physical inactivity and genetic factors according to DeFronzo et al. (2018). The onset of T2DM happens gradually and patients can initially control their condition through changes in diet and physical activity without insulin. In various treatment situations, patients need medications such as insulin or oral hypoglycemic agents for proper blood sugar control according to Lean et al. (2019).

Gestational Diabetes Mellitus

Pregnant women might develop GDM from hormonal variations that create insulin dysfunction and result in insulin resistance (Buchanan & Xiang, 2021). The presence of gestational diabetes ends following childbirth but affected pregnant mothers face a higher danger of developing Type 2 diabetes subsequently (ADA, 2022). Maternal and fetal health requires accurate prenatal care as well as proper dietary management and insulin therapy as needed (Taylor et al., 2019).

Symptoms of Diabetes Mellitus

The signs of diabetes mellitus develop different intensities depending on blood glucose level measurements in each person. The progression of symptoms occurs slowly during type 2 diabetes but symptoms generally appear suddenly in type 1 diabetes patients (Papatheodorou et al., 2018). Polyuria is a primary symptom of diabetes that happens when excess blood glucose drains water from body tissues and generates increased urine output (ADA, 2022). Persistent thirst sets in when the body loses too much fluid along with polydipsia because dehydration becomes a problem (Nathan et al., 2020).

The body’s cells fail to convert glucose into energy leading to polyphagia or increased hunger which develops as a result (Zimmet et al., 2021). The hunger sensation persists for diabetes patients even after they accept a sufficient amount of food. Weight loss emerges in patients with type 1 diabetes because their insulin deficiency leads the body to use energy from muscle and fat stores (Knip et al., 2020). The improper utilization of glucose results in fatigue alongside common symptoms of low energy levels and tiredness (Taylor et al., 2019).

Cases of blurred vision occur often in people with high blood glucose levels because these levels modify how the lens emerges (WHO, 2021). The combination of elevated blood glucose levels produces two negative effects disrupting blood circulation and weakening immune response which results in stubborn skin wounds that frequently become infected (Holt et al., 2021). The infection rates among people with diabetes increase because they develop frequent urinary tract infections, skin infections, and fungal infections (Buchanan & Xiang, 2021). Secure detection of these symptoms at an early stage leads to prompt medical diagnosis and treatment which protects against further complications and supports better health achievements (Papatheodorou et al., 2018).

Pathophysiology of Diabetes Mellitus

Causes and Risk Factors of Diabetes Mellitus

Diabetes mellitus exists as a complex metabolic condition that develops from both genetic elements alongside environmental and lifestyle influences. Diabetes develops from different fundamental causes yet all types share common risk elements in their progression.

Causes of Diabetes Mellitus

Type 1 Diabetes Mellitus (T1DM): T1DM develops because of an autoimmune reaction that mistaken activates the immune system to destroy insulin-producing beta cells inside the pancreas (Gale, 2020). The condition results in complete insulin deficiency therefore people with this type need lifelong insulin therapy. Genetic risks together with viral infections serve as environmental factors that appear to initiate T1DM according to Knip et al. (2020).

Type 2 Diabetes Mellitus (T2DM):

Insulin resistance causes T2DM by creating an unresponsive condition among body cells which results in elevated blood glucose levels. INSUFFICIENT insulin production becomes a problem for pancreatic beta cells during long-term progression (DeFronzo et al., 2018). The combination of obesity, physical inactivity, and unhealthy eating habits causes insulin resistance, and genetic background significantly affects disease tendency (Zimmet et al., 2021).

Gestational Diabetes Mellitus (GDM): A pregnant woman develops GDM because the hormonal adjustments of pregnancy make her body more resistant to insulin. The condition of GDM ends naturally after delivery but pregnant women with GDM experience higher odds of developing type 2 diabetes in the future (Buchanan & Xiang, 2021) miscarriages and complications between mothers and newborns develop from inadequate blood sugar regulation during pregnancy because it makes macrosomia and neonatal hypoglycemia more likely (ADA, 2022).

Risk Factors for Diabetes Mellitus

Diabetes mellitus risk factors stem from various aspects that combine genetics with lifestyle conduct and total health situation. The incidence of diabetes is higher for people who have relatives with diabetes because of genetic inheritance (Taylor et al., 2019). Type 1 diabetes mellitus (T1DM) exists primarily due to autoimmune actions yet type 2 diabetes mellitus (T2DM) develops from inherited insulin resistance (Knip et al., 2020).

The combination of obesity with physical inactivity results in T2DM development through mechanisms connecting high body weight especially visceral fat to insulin resistance and disrupted glucose metabolism (Zimmet et al., 2021). Physical inactivity magnifies diabetes risks because it lowers insulin function and escalates weight problems. The development of diabetes heavily depends on an unhealthy dietary pattern since consuming large amounts of saturated fats and refined carbohydrates combined with sugary beverages tends to cause insulin resistance and metabolic disorders (DeFronzo et al., 2018).

High blood pressure together with abnormal cholesterol measurements act as important diabetes risk factors. Higher blood pressure values together with abnormal cholesterol levels result in damaged blood vessels and metabolic imbalances that increase the probability of developing T2DM (Nathan et al., 2020). Humans become more prone to diabetes as their medical year progresses because insulin sensitivity naturally deteriorates with age. The T2DM risk becomes notably higher at age 45 and older as pancreatic performance and metabolic operation decline among elderly patients (WHO, 2021).

Controlling risk factors like diet physical exercise and weight management effectively decreases diabetes development. Early detection of high-risk patients through regular health screenings becomes vital for implementing preventive programs according to Holt et al. (2021).

Diagnosis

Diabetes is diagnosed using the following tests:

(Source: ADA, 2022)

The treatment of diabetes mellitus (DM) regulates blood glucose levels effectively to reduce risks of complications and improve general health benefits. The therapy options for diabetes depend specifically on the diabetes form and individual patient needs. People with Type 1 diabetes mellitus (T1DM) need insulin therapy because their bodies lack insulin production while Type 2 diabetes mellitus (T2DM) and gestational diabetes mellitus (GDM) can sometimes be managed by lifestyle changes and drugs as well as the combination of both strategies.

Treatment of Type 1 Diabetes Mellitus (T1DM)

T1DM exists as an autoimmune disorder that causes immune response destruction of pancreatic beta cells which creates an absolute insulin deficiency (Holt et al., 2021). T1DM patients need permanent insulin treatment for their survival to continue living. The key treatment strategies include:

Insulin Therapy: External insulin administration has become vital because the pancreas remains unable to produce insulin which results in necessary blood glucose regulation. The treatment of type 1 diabetes takes effect through multiple daily injections (basal-bolus therapy) and continuous subcutaneous insulin infusion (insulin pump therapy) methods which efficiently control blood glucose levels (Knip et al., 2020).

Dietary Management:  Individuals who follow carbohydrate counting methods along with meal planning have a technique to administer insulin doses according to their food consumption. Patients should consume a balanced diet consisting of whole grains together with lean proteins and healthy fats to avoid rapid changes in their blood sugar levels. The maintenance of proper hydration and portion sizes plays critical roles together in the stabilization of blood glucose levels (ADA, 2022).

Exercise:  Regular exercise helps increase how well the body processes insulin which results in improved glucose efficiency. People with T1DM need to measure their blood glucose constantly before working out and throughout workout periods and recovery to stop hypoglycemia from happening. The level of physical activity determines both insulin dosage adjustments and carbohydrate consumption according to Holt et al. (2021).

Treatment of Type 2 Diabetes Mellitus (T2DM)

T2DM exists as the most prevalent diabetes type which combines insulin resistance with a deficiency of relative insulin levels. The management of this condition aims to enhance insulin responsiveness by implementing lifestyle changes together with medication treatments (Lean et al., 2019).

Lifestyle Modifications: Successful T2DM treatment relies on eating healthfully along with controlling weight properly while exercising regularly. People who eat food that is high in nutrients while cutting back on processed sugars and adding more fibers maintain normal blood glucose levels in their bodies. People who manage to reduce their body weight, particularly around the abdominal area will experience improved insulin sensitivity while decreasing their insulin resistance severity (Zimmet et al., 2021).

Oral Medications: Therapists initiate T2DM medication with metformin because the drug boosts insulin activity and lowers blood sugar production from the liver. Different oral medications including sulfonylureas, DPP-4 inhibitors, and SGLT2 inhibitors serve as alternative treatment options for individual patient requirements (Nathan et al., 2020).

Insulin Therapy: The proper use of insulin injections becomes essential for patients with advanced cases of diabetes whose blood glucose remains out of control with oral medications. Medical practitioners introduce insulin treatment as a gradual process combined with oral medications until a patient requires complete insulin dependency (Lean et al., 2019).

Treatment of Gestational Diabetes Mellitus (GDM)

GDM establishes itself during pregnancy as a short-term medical condition because hormonal modifications create insulin resistance among pregnant women. Those with GDM need proper medical care because inadequate control may result in medical problems for mothers and babies such as macrosomia, preeclampsia, and neonatal hypoglycemia (ADA, 2022).

Dietary Control: The fundamental strategy to control Gestational Diabetes Mellitus depends on foods with a low Glycemic Index diet and precise carbohydrate management. Splitting food portions into smaller meals throughout the day can stop blood sugar concentrations from changing dramatically. The balance of glucose requires proper hydration and fiber consumption according to Buchanan and Xiang (2021).

Insulin Therapy: Insulin therapy stands as the treatment option for women whose blood sugar levels fail to respond to lifestyle modifications. During pregnancy insulin treatment presents safety advantages for the expectant mother and her developing baby because it does not cause harm to either. Blood glucose testing must occur frequently during pregnancy to achieve proper control and stop complications from developing (ADA, 2022).

Insulin Resistance in Type 2 Diabetes

Preventative Procedures for Diabetes Mellitus

The prevention of diabetes mellitus (DM) needs both lifestyle changes and medical treatment which specifically benefits those who carry a high risk of diabetes development. Early clinical interventions produce major decreases in the developing of type 2 diabetes mellitus (T2DM) together with its connected health issues.

Lifestyle Modifications

Healthy Diet: Diagnosis of diabetes depends heavily on implementing a nutritious meal plan. A dietary plan that consists of fibers in combination with reduced fat and managed carbohydrates supports blood sugar balance and increases insulin responsiveness (Pan et al., 2017). A person needs to prioritize whole grains along with lean proteins and fruits and vegetables while reducing their consumption of processed foods and sugary beverages.

Regular Exercise: Exercise boosts how well insulin works inside the body and simultaneously supports weight control. The American Diabetes Association endorses doing moderate-intensity exercise for a minimum of 150 minutes each week including activities like walking, cycling, and swimming (Knowler et al., 2018). Strengthening exercises lead to increased glucose absorption in muscles along with overall health improvements in metabolism.

Weight Management: T2DM presents a major health risk to individuals who are obese. People who balance their diet with exercise to achieve and keep a standard body mass index rate lower their chances of developing insulin resistance and metabolic disorders (Knowler et al., 2018). Reduced weight by 5 to 10 percent leads to major reductions in the chance of developing diabetes.

Smoking Cessation: Research shows that smoking creates higher diabetes susceptibility as well as increases the chance of developing cardiovascular disease and neuropathy (Huang et al., 2019). The health benefits that come from smoking cessation along with better insulin sensitivity reduce the chances of diabetes diagnosis.

Conclusion

Health professionals recognize diabetes mellitus as a prevalent worldwide medical issue requiring prompt diagnosis and suitable treatments alongside preventive methods to minimize its effects. The requirement for lifelong insulin therapy exists in T1DM because of insulin deficiency but T2DM patients can avoid its development by implementing healthy dietary choices coupled with exercise and proper weight control. Fetal and maternal health needs constant monitoring during GDM since it poses risks for both conditions. The prevention of cardiovascular disease along with neuropathy and kidney damage depends on maintaining regular blood glucose monitoring and strict adherence to treatment plans and prompt interventions. Treatment methods that blend medical supervision with lifestyle modifications lead to improved patient healthcare results as well as enhanced life quality.

References

American Diabetes Association. (2022). Standards of medical care in diabetes—2022. Diabetes Care, 45(S1), S1-S282.

Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type 1 diabetes. The Lancet, 383(9911), 69-82.

Berbudi, A., Rahmadika, N., Tjahjadi, A. I., & Ruslami, R. (2020). Type 2 diabetes and its impact on the immune system. Current Diabetes Reviews, 16(5), 442-449.

Buchanan, T. A., & Xiang, A. H. (2021). Gestational diabetes mellitus. The Journal of Clinical Investigation, 131(1).

Chatterjee, S., Khunti, K., & Davies, M. J. (2017). Type 2 diabetes. The Lancet, 389(10085), 2239-2251.

DeFronzo, R. A., et al. (2018). Pathophysiology of type 2 diabetes mellitus. Medical Clinics of North America, 102(1), 1-17.

Egan, A. M., & Dinneen, S. F. (2019). What is gestational diabetes mellitus? QJM: An International Journal of Medicine, 112(8), 509-514.

Forbes, J. M., & Cooper, M. E. (2019). Mechanisms of diabetic complications. Physiological Reviews, 99(1), 137-187.

Gale, E. A. M. (2020). The rise of childhood type 1 diabetes in the 20th century. Diabetes, 69(3), 265-271.

Gregg, E. W., & Sattar, N. (2016). Prevention of type 2 diabetes: Current evidence and future research requirements. The Lancet, 387(10027), 1519-1521.

Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., & Klupa, T. (2021). The management of type 1 diabetes in adults. Diabetes Therapy, 12(1), 255-278.

Huang, Y., Karuranga, S., Malanda, B., & Williams, D. R. R. (2019). IDF diabetes atlas. International Diabetes Federation, 9(1).

International Diabetes Federation (IDF). (2021). Diabetes Atlas (10th ed.). Brussels: IDF.

Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A., & Nathan, D. M. (2018). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393-403.

Knip, M., Siljander, H., & Veijola, R. (2020). Advances in type 1 diabetes mellitus. New England Journal of Medicine, 383(12), 1073-1081.

Lean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., & Taylor, R. (2019). Primary care-led weight management for remission of type 2 diabetes (DiRECT). The Lancet, 391(10120), 541-551.

Lilly, D. M., Maahs, D. M., & Wadwa, R. P. (2021). Screening and prevention of type 2 diabetes mellitus. Journal of Clinical Endocrinology & Metabolism, 106(5), 1278-1287.

Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., & Zinman, B. (2020). Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care, 30(3), 753-759.

Pan, X. R., Li, G. W., Hu, Y. H., Wang, J. X., Yang, W. Y., An, Z. X., & Howard, B. V. (2017). Effects of diet and exercise in preventing type 2 diabetes in high-risk individuals. Diabetes Care, 20(4), 537-544.

Papatheodorou, K., Banach, M., Bekiari, E., Rizzo, M., & Edmonds, M. (2018). Complications of diabetes. Journal of Diabetes Research, 2018, 3086167.

Seida, J. C., Mitri, J., & Colmers, I. N. (2020). Comparative effectiveness of type 2 diabetes prevention programs. Diabetes Care, 44(3), 720-728.

Taylor, R., Barnes, A. C., & Lean, M. E. J. (2019). From weight loss to remission in type 2 diabetes: A review. Diabetes, Obesity & Metabolism, 21(3), 20-35.

Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., & Uusitupa, M. (2017). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine, 344(18), 1343-1350.

UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. The Lancet, 352(9131), 837-853.

Vijan, S. (2019). Type 2 diabetes. Annals of Internal Medicine, 171(9), ITC65-ITC80.

Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes. Diabetes Care, 27(5), 1047-1053.

World Health Organization (WHO). (2021). Global report on diabetes. WHO Press, 1(1), 1-88.

Xu, G., Liu, B., Sun, Y., Du, Y., Snetselaar, L. G., Hu, F. B., & Bao, W. (2018). Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017. BMJ Open Diabetes Research & Care, 6(1), e000650.

Zimmet, P., Alberti, K. G. M. M., Magliano, D. J., & Bennett, P. H. (2021). Global trends in diabetes epidemiology. Diabetes Research and Clinical Practice, 175, 108815.

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., & Johansen, O. E. (2015). Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine, 373(22), 2117-2128.